Terms: = Uterine cancer AND BRCA1, BRCAI, 672, ENSG00000012048, IRIS, BRCC1, RNF53, PSCP
406 results:
1. The analysis of preoperative or intraoperative factors in predicting the escalation of surgical pathological staging of patients with clinical stage I endometrioid carcinoma: A retrospective clinical study.
Li N; Chen Q; Li B
Medicine (Baltimore); 2024 Mar; 103(11):e37465. PubMed ID: 38489719
[TBL] [Abstract] [Full Text] [Related]
2. Laparoscopic continuous seromuscular circumsuture for myomectomy: a real-world, retrospective, East-Asian cohort study.
Shi X; Wu H; Liu J; Zhu J; Zhang L
BMJ Open; 2024 Mar; 14(3):e081550. PubMed ID: 38458810
[TBL] [Abstract] [Full Text] [Related]
3. BRCA 1/2 mutations and risk of uterine cancer: a systematic review and meta-analysis.
Zakerinasab F; Behfar Q; Parsaee R; Zadeh RH; Foroughi E; Amirbeik A; Ahmadi G
BMC Genom Data; 2024 Jan; 25(1):13. PubMed ID: 38297203
[TBL] [Abstract] [Full Text] [Related]
4. Microsatellite Instability Is Insufficiently Used as a Biomarker for Lynch Syndrome Testing in Clinical Practice.
Papadopoulou E; Rigas G; Fountzilas E; Boutis A; Giassas S; Mitsimponas N; Daliani D; Ziogas DC; Liontos M; Ramfidis V; Christophilakis C; Matthaios D; Floros T; Florou-Chatzigiannidou C; Agiannitopoulos K; Meintani A; Tsantikidi A; Katseli A; Potska K; Tsaousis G; Metaxa-Mariatou V; Nasioulas G
JCO Precis Oncol; 2024 Jan; 8():e2300332. PubMed ID: 38271656
[TBL] [Abstract] [Full Text] [Related]
5. Predictive and prognostic biomarkers in female genital tract tumours: an update highlighting their clinical relevance and practical issues.
Wong RW; Cheung ANY
Pathology; 2024 Mar; 56(2):214-227. PubMed ID: 38212229
[TBL] [Abstract] [Full Text] [Related]
6. Germline BRCA2 variant with low variant allele frequency detected in tumor-only comprehensive genomic profiling.
Hayashi H; Kunimasa K; Tanishima S; Nakamura K; Ishikawa M; Kato Y; Aimono E; Kawano R; Nishihara H
Cancer Sci; 2024 Feb; 115(2):682-686. PubMed ID: 38086530
[TBL] [Abstract] [Full Text] [Related]
7. Endometrial cancer Risk Among Germline
Sorouri K; Lynce F; Feltmate CM; Davis MR; Muto MG; Konstantinopoulos PA; Stover EH; Kurian AW; Hill SJ; Partridge AH; Tolaney SM; Garber JE; Bychkovsky BL
JCO Precis Oncol; 2023 Sep; 7():e2300290. PubMed ID: 38061009
[TBL] [Abstract] [Full Text] [Related]
8. Globally shared TCR repertoires within the tumor-infiltrating lymphocytes of patients with metastatic gynecologic cancer.
Kim T; Lim H; Jun S; Park J; Lee D; Lee JH; Lee JY; Bang D
Sci Rep; 2023 Nov; 13(1):20485. PubMed ID: 37993659
[TBL] [Abstract] [Full Text] [Related]
9. Concurrent uterine surgery and uptake of hormone therapy in patients undergoing bilateral salpingo-oophorectomy for risk-reducing or therapeutic indications.
Sasse SA; Lee SS; Rajeev P; Sharma SR; Kahan T; Pothuri B
Gynecol Oncol; 2023 Dec; 179():131-137. PubMed ID: 37988946
[TBL] [Abstract] [Full Text] [Related]
10. Age-stratified risk factors of re-intervention for uterine fibroids treated with high-intensity focused ultrasound.
Tang NH; Fang CL; Hu WH; Tian L; Lin C; Hu HQ; Shi QL; Xu F
Int J Gynaecol Obstet; 2024 Mar; 164(3):1212-1219. PubMed ID: 37953647
[TBL] [Abstract] [Full Text] [Related]
11. NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024.
Daly MB; Pal T; Maxwell KN; Churpek J; Kohlmann W; AlHilli Z; Arun B; Buys SS; Cheng H; Domchek SM; Friedman S; Giri V; Goggins M; Hagemann A; Hendrix A; Hutton ML; Karlan BY; Kassem N; Khan S; Khoury K; Kurian AW; Laronga C; Mak JS; Mansour J; McDonnell K; Menendez CS; Merajver SD; Norquist BS; Offit K; Rash D; Reiser G; Senter-Jamieson L; Shannon KM; Visvanathan K; Welborn J; Wick MJ; Wood M; Yurgelun MB; Dwyer MA; Darlow SD
J Natl Compr Canc Netw; 2023 Oct; 21(10):1000-1010. PubMed ID: 37856201
[TBL] [Abstract] [Full Text] [Related]
12. Survey of NF1 inactivation by surrogate immunohistochemistry in ovarian carcinomas.
Köbel M; Yang RZ; Kang EY; Al-Shamma Z; Cook LS; Kinloch M; Carey MS; Hopkins L; Nelson GS; McManus KJ; Vizeacoumar FS; Vizeacoumar FJ; Freywald A; Fu Y; Reuss DE; Lee CH
Gynecol Oncol; 2023 Nov; 178():80-88. PubMed ID: 37820398
[TBL] [Abstract] [Full Text] [Related]
13. Ovarian squamous cell carcinoma associated with teratoma: a report of six cases with genomic analysis.
Liang Y; Ruan H; Yu M; Lü B
Pathology; 2023 Dec; 55(7):966-973. PubMed ID: 37739924
[TBL] [Abstract] [Full Text] [Related]
14. Report on the Effect of the Implementation of an Early Detection and Prevention of cancer Program on Families at High Hereditary Risk-Concentrating on Patients Undergoing Genetic Diagnostics and Counseling in Central Poland.
Kałużewski T; Kubiak I; Bednarek M; Sałamunia J; Kucharska D; Kępczyński Ł; Stempień M; Kubicki T; Trzciński R; Gordon-Sönmez Z; Bartosińska-Dyc A; Gach A; Kałużewski B
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685988
[TBL] [Abstract] [Full Text] [Related]
15. Risk of endometrial cancer after RRSO in BRCA 1/2 carriers: a multicentre cohort study.
Pla-Juher H; Pardo M; Izquierdo ÀJ; Darder E; Carbó A; Munté E; Torres-Esquius S; Balmaña J; Lázaro C; Brunet JM; Barretina-Ginesta MP
Clin Transl Oncol; 2024 Apr; 26(4):1033-1037. PubMed ID: 37682500
[TBL] [Abstract] [Full Text] [Related]
16. Ovarian high-grade serous carcinoma with transitional-like (SET) morphology: a homologous recombination-deficient tumor.
D'Angelo E; Espinosa I; Felicioni L; Buttitta F; Prat J
Hum Pathol; 2023 Nov; 141():15-21. PubMed ID: 37673346
[TBL] [Abstract] [Full Text] [Related]
17. Prevalence and Landscape of Pathogenic or Likely Pathogenic Germline Variants and Their Association With Somatic Phenotype in Unselected Chinese Patients With Gynecologic cancers.
Wen H; Xu Q; Sheng X; Li H; Wang X; Wu X
JAMA Netw Open; 2023 Jul; 6(7):e2326437. PubMed ID: 37523182
[TBL] [Abstract] [Full Text] [Related]
18. Contrast-Enhanced Ultrasonography for Transabdominal and Transrectal Ultrasound in Staging Cervical cancer: A Reliability Study.
Zhang J; Xiang JD; Jia C; Du LF; Li F
Ultrasound Med Biol; 2023 Oct; 49(10):2283-2290. PubMed ID: 37495499
[TBL] [Abstract] [Full Text] [Related]
19. LCK facilitates DNA damage repair by stabilizing RAD51 and brca1 in the nucleus of chemoresistant ovarian cancer.
Dey G; Bharti R; Braley C; Alluri R; Esakov E; Crean-Tate K; McCrae K; Joehlin-Price A; Rose PG; Lathia J; Gong Z; Reizes O
J Ovarian Res; 2023 Jun; 16(1):122. PubMed ID: 37370140
[TBL] [Abstract] [Full Text] [Related]
20. Uptake and barriers to cervical cancer screening among human immunodeficiency virus-positive women in Sub Saharan Africa: a systematic review and meta-analysis.
Mengesha MB; Chekole TT; Hidru HD
BMC Womens Health; 2023 Jun; 23(1):338. PubMed ID: 37370091
[TBL] [Abstract] [Full Text] [Related]
[Next]
